Search
for
Sort by
Research 31–60 of 1000+
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Hair, Hormones, and High-Risk Prostate Cancer
- Morpho‐regulation in diverse chicken feather formation: Integrating branching modules and sex hormone‐dependent morpho‐regulatory modules
- Hormone-dependent medial preoptic/lumbar spinal cord/autonomic coordination supporting male sexual behaviors
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank
- Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
- Is dehydroepiandrosterone a hormone?
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Prostate cancer update: 2007
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Incidence of alopecia from endocrine therapies in cancer
- Prostate cancer update: 2007
- The role of androgens in hormone replacement therapy
- Gender-Affirming Hormone Therapy for Transgender Men
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- Cross-sex hormone therapy for gender dysphoria
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Selective induction of apoptosis in the hamster flank sebaceous gland organ by a topical liposome 5-α-reductase inhibitor: A treatment strategy for acne
- Omega-6 highly unsaturated fatty acids in Leydig cells facilitate male sex hormone production
- N-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase
- Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life
- Pharmacology of antiandrogens
- Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells